Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Matthew Ronsheim > Profile

Matthew Ronsheim

Affiliations

  • See Remarks at Innoviva Inc. (INVA), 2024-03-08
  • Chief Of Pharma Sciences & Mfg at Entasis Therapeutics Holdings Inc. (ETTX), 2022-07-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Entasis Therapeutics Holdings Inc.
 ETTX $3.19 3,759 Officer 46,241 2021-10-19 Filing